Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (511-520 of 874) with videos related to

Pageof 88
Sort By:
Scandinavian Journal of Immunology|June 13, 2006
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapyS R Ostrowski, T L Katzenstein, M Pedersen, et al.
Journal of Pediatric Hematology/Oncology|September 20, 2014
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 NeuroblastomaShravan Kandula, Roshan S Prabhu, Ronica Nanda, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Role of conformational changes in the elution of proteins from reversed-phase HPLC columnsG E Katzenstein, S A Vrona, R J Wechsler, et al.
Journal of Virus Eradication|April 24, 2018
Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case-control study from Copenhagen, DenmarkMaria Wessman, Anne-Sofie Korsholm, Janne Gasseholm Bentzen, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
BMC Public Health|October 4, 2013
Early infant diagnosis of HIV in three regions in Tanzania; successes and challengesMercy G Chiduo, Bruno P Mmbando, Zahra P Theilgaard, et al.
Journal of the International AIDS Society|July 13, 2013
Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and AfricaSally Land, Julian Zhou, Philip Cunningham, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infectionD A Katzenstein, M D Hughes, M Albrecht, et al.
Pageof 88

Showing results (511-520 of 874) with videos related to

Sort By:
Pageof 88
Scandinavian Journal of Immunology|June 13, 2006
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapyS R Ostrowski, T L Katzenstein, M Pedersen, et al.
Journal of Pediatric Hematology/Oncology|September 20, 2014
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 NeuroblastomaShravan Kandula, Roshan S Prabhu, Ronica Nanda, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Role of conformational changes in the elution of proteins from reversed-phase HPLC columnsG E Katzenstein, S A Vrona, R J Wechsler, et al.
Journal of Virus Eradication|April 24, 2018
Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case-control study from Copenhagen, DenmarkMaria Wessman, Anne-Sofie Korsholm, Janne Gasseholm Bentzen, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
BMC Public Health|October 4, 2013
Early infant diagnosis of HIV in three regions in Tanzania; successes and challengesMercy G Chiduo, Bruno P Mmbando, Zahra P Theilgaard, et al.
Journal of the International AIDS Society|July 13, 2013
Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and AfricaSally Land, Julian Zhou, Philip Cunningham, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infectionD A Katzenstein, M D Hughes, M Albrecht, et al.
Pageof 88